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7 ABSTRACT: Many biological processes are regulated by
8 reversible binding events, with these interactions between
9 macromolecules representing the core of dynamic chemistry.
10 As such, any attempt to gain a better understanding of such
11 interactions, which would pave the way to the extrapolation of
12 natural designs to create new advanced systems, is clearly of
13 interest. This work focuses on the development of a leucine
14 zipper-elastin-like recombinamer (ZELR) in order to elucidate
15 the behavior of such domains when coexisting along the same
16 molecule and to engineer reversible, injectable and stable hydrogels. The unique propensity of the Z-moiety selected to dimerize,
17 together with the thermosensitive behavior of the ELR, which has been constructed as a thermosensitive amphiphilic tetrablock,
18 has been engineered into a single recombinant molecule. In this molecular design, the Z-moieties are unable to form a network,
19 while the ELR is below its Tt, thus, guaranteeing the liquid-like state of the system. However, this situation changes rapidly as the
20 temperature increases above Tt, where a stable hydrogel is formed, as demostrated by rheological tests. The inability of the ELR
21 molecule (without Z-domains) to form such a stable hydrogel above Tt clearly points to a positive cooperative eﬀect between
22 these two domains (Z and EL), and no conformational changes in the former are involved, as demonstrated by circular dichroism
23 analysis. AFM shows that Z-motifs seem to induce the aggregation of micelles, which supports the enhanced stability displayed by
24 ZELRs when compared to ELR at the macroscale level. To the best of our knowledge, this is the ﬁrst time that such an interplay
25 between these two domains has been reported. Furthermore, the cytocompatibility of the resulting hydrogels opens the door to
26 their use in biomedical applications.
27 ■ INTRODUCTION
28 The ability of many proteins to switch between diﬀerent
29 oligomerization states is a pivotal tool for controlling their
30 functionality in Nature,1 with ligand binding, catalytic activity,
31 and a highly ordered organization being just some of the
32 advantages provided by an ability to oligomerize.1 A rational
33 knowledge of the parameters that determine protein con-
34 formation and protein−protein interactions is crucial for the
35 design of artiﬁcial bioinspired novel devices that are able to
36 change their aggregated state in an environmentally dependent
37 manner. An ability to undergo such a process in response to a
38 controllable and relevant external stimuli paves the way for the
39 development of nanosensors, molecular transducers, and
40 stimuli-sensitive materials in general.
41 In this regard, α-helical coiled-coils are known to be
42 responsible for oligomerization in a wide spectrum of proteins.2
43 The so-called leucine zippers (Z) are an interesting group of α-
44 helical domains3 characterized by heptad repeating units
45 designated “abcdefg”, where the “a” and “d” positions are
46 occupied by hydrophobic residues such as leucine4,5 and the “e”
47 and “g” positions are occupied by charged residues.6 Each
48 coiled-coil domain folds into an amphiphilic α-helix that places
49 the “a” and “d” residues on a hydrophobic face, with
50hydrophobic interactions driving these helices to associate in
51a coiled-coil fashion.7
52Following the school of thought of bioinspiration, which is
53characterized by the transfer of designs found in Nature to
54create new and advanced systems in the laboratory, the ability
55of Z-moieties to oligomerize has been extrapolated to the
56creation of physical hydrogels.8−10 The ﬁrst Z-based self-
57assembled hydrogel was developed by Petka et al.,11 and since
58then, further research in this area has resulted in additional
59examples being reported.8,9,12 Despite this, further optimization
60is still required for real applications. For example, the instability
61of these hydrogels has always been a handicap, presumably due
62to the highly hydrophilic environment created by the aqueous
63media contained within the hydrogel and, in many cases, gel
64formation has been qualitatively assessed, and with just a few
65exceptions, quantitative measurement using rheological meth-
66ods has proved elusive.8,9 It is worth mentioning that George et
67al. reported an optimized version of Tirrel’s published zipper
68moieties that was able to form stable zipper-based scaﬀolds,10
69although additional issues remain unsolved. For example,
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70 geliﬁcation takes 3 h, which hampers most of the potential uses
71 of such systems, such as the development of injectable
72 hydrogels.10 Moreover, the examples of Z-based systems
73 found in the literature tend to focus on a limited number of
74 Z-sequences, which in many cases are artiﬁcially designed. As
75 such, further exploration is still required in order to fully exploit
76 the properties that Z-moieties can bring to the ﬁeld of
77 biomaterials science and nanotechnology.
78 Taking all this information into account, our working
79 hypothesis is the creation of a novel hybrid molecule, based
80 on Z-domains that are able to form stable, reversible, and
81 injectable hydrogels whose transition between the liquid-like
82 and the gel-like state can be easily controlled by temperature.
83 To this end, Z-domains have been combined with an
84 amphiphilic tetrablock elastin-like recombinamer (ELR) to
85 give a ﬁnal molecule (ZELR) that combines the properties of
86 the zipper with the thermal responsiveness of the ELR.
87 ELRs are protein-based materials whose composition is
88 inspired by the primary sequence found in natural elastin.13
89 Thus, the amino-acid sequence of ELRs commonly comprises
90 repeats of the (VPGXG) pentapeptide, where X can be any
91 amino acid except proline. ELRs show a reversible phase
92 transition in response to temperature. In an aqueous medium
93 and below a characteristic temperature known as the inverse
94 transition temperature (Tt), the recombinamer chain remains
95 soluble. However, above this Tt, the ELR assembles hydro-
96 phobically and adopts a regular, dynamic, and nonrandom
97 structure identiﬁed by a succession of β-turns.14,15
98 The amphiphilic tetrablock ELR used here has been reported
99 previously.16,17 Brieﬂy, it comprises two hydrophilic blocks
100 containing VPGEG pentapeptides along their sequence (in
101 which E stands for glutamic acid) and two thermally sensitive
102 hydrophobic blocks, the pentapeptides of which contain
103 isoleucine as guest residue. The hydrophilic blocks are
104 responsible for water retention within the network of the
105 hydrogel thanks to the ionized state of the carboxyl side chain
106 of E amino acid at neutral pH,18 whereas the hydrophobic ones
107 are responsible for mediating the physical cross-linking
108 (hydrophobic associations) on increasing the temperature
109 above its characteristic Tt.16 However, this tetrablock molecule
110 is unable to form a stable hydrogel, losing its integrity in
111 contact with an excess of aqueous medium. The gel swells
112 under these conditions, and ﬁnally, at a molecular level, the
113 material goes from a cross-linked hydrogel to a micellar
114 dispersion.17
115 The Z-sequence used in the molecular designed ZELRs
116 developed in this work, known as HLF,19 belongs to a natural
117 class of human zippers, and the extrapolation of its functionality
118 to the development of new and advanced systems and
119 biomaterials has not been studied to any extent. The HLF
120 sequence belongs to the PAR family of human B-ZIP proteins,
121 which is considered to be the canonical homodimerizing
122 leucine zipper.19 The choice of this sequence was motivated by
123 the accurate adjustment of this human sequence to the
124 established knowledge of stable dimeric coiled−coil inter-
125 actions.19 Moreover, since our understanding of the structure−
126 property relationships in this class of materials is limited, in
127 addition to studying the natural HLF sequence as a means of
128 obtaining such hydrogels, we have also constructed a mutated
129 version in order to shed light on the molecular design principles
130 and to obtain valuable experimental information regarding
131 tailoring of the material’s properties.
132The main aim of this work is to explore the feasibility of
133combining Z- and EL-moieties in the same molecule to obtain
134stable and injectable hydrogels, and to elucidate whether such
135self-assembled motifs can cooperate when coexisting along the
136same molecule in order to further understand the behavior of
137multidomain systems. To this end, two new ZELRs have been
138designed, produced, and studied, and their geliﬁcation behavior,
139the stability of the hydrogels formed, their structural character-
140istics at both the nano and the molecular level, and their
141cytocompatibility are reported in this work.
142■ EXPERIMENTAL SECTION
143Construction of ELR and ZELR. Gene synthesis was carried out
144using standard molecular biology protocols. Sequential introduction of
145the repetitive EL- or Z-polypeptide-coding gene segments to form
146fusion genes with a fully controlled composition and chain length was
147carried out using a “recursive directional ligation” (RDL) strategy.20
148To perform such strategy, it is necessary to create coding gene
149segments ﬂanked at both ends with nonpalindromic restriction sites.
150Speciﬁcally, in the present work, gene segments encoding each
151monomer were contained in a modiﬁed version of the cloning vector
152pDrive (Qiagen), named as pDAll, which is characterized by the
153engineering of two inverted Eam 1104 I and one SapI restriction sites
154in the poly-linker region. Thus, the gene sequence encoding each
155monomer cloned in pDAll vector is ﬂanked by Eam 1104 I and SapI
156recognition sites in 5′ termini and Eam 1104 I site at 3′ termini.
157According to the engineering restriction sites, the restriction type II
158enzymes Eam 1104 I and SapI were used. The asymmetrical
159extremities of three nucleotides generated by Sap I are of the same
160size and orientation as the ones generated by Eam 1104 I
161endonuclease, which allowed a controlled and sequential concate-
162nation of the gene segments, resulting in a multiblock-coding gene.
163The sequences were veriﬁed by agarose gel electrophoresis of the
164restriction fragments generated after enzymatic digestion and
165automated DNA sequencing. Selected genes were subcloned into a
166modiﬁed pET-25(+) expression vector and then transformed into the
167E. coli strain BLR(DE3)star (Invitrogen).
168ZELR Production and Puriﬁcation. The puriﬁcation protocol
169consisted of sequential rounds of inverse transition cycling (ITC)
170optimized according to the speciﬁc characteristics of each
171recombinamer.
172The soluble fraction obtained at the end of the lysis process of E.
173coli expression colonies was acidiﬁed to pH 4 by addition of diluted
174hydrochloric acid. The denatured material (acid proteins and DNA)
175were removed by cold centrifugation at 15000 × g for 30 min. This
176step was perfomed at 4 °C to avoid the transition and subsequent
177aggregation of our recombinamers. The next step consisted on the
178addition of NaCl 2 M to the soluble fraction, and heating at 42 °C for
1791 h. Subsequently, centrifugation at 42 °C was performed, and the
180insoluble fraction was resuspended by cold ultrapure deionized water.
181Afterward, cold centrifugation was performed, and the soluble fraction
182was subjected to two more additional cycles of heating couple with
183NaCl and cool resuspension. Finally, the recombinamers were
184subjected to dialysis and lyophilized.
185The purity and molecular weight of the recombinamers were
186routinely determined by sodium dodecyl sulfate polyacrylamide gel
187electrophoresis (SDS-PAGE) and mass spectrometry (MALDI-TOF/
188MS). The amino acid composition was further veriﬁed by HPLC
189analysis. NMR (nuclear magnetic resonance) analysis was also carried
190out in order to ensure the absence of nonproteinaceous organic
191impurities. In order to characterize the ITT behavior of the
192recombinamers, DSC experiments were performed using a Mettler
193Toledo 822e with liquid-nitrogen cooler. The solutions for the DSC
194experiments were prepared at 5 wt % in an aqueous buﬀered solution
195(PBS). A total of 20 μL of the corresponding solution was placed
196inside a standard 40 μL aluminum pan, which was then sealed
197hermetically. The heating program for DSC experiments included an
198initial isothermal stage (5 min at 0 °C for stabilization of the
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199 temperature and the state of the recombinamers), followed by heating
200 at 5 °C/min from 0 to 60 °C.
201 Visualization of the Sol−Gel Behavior. The 15 wt % aqueous
202 solutions of (EI-ZC)×2, (EI-ZL)×2, and (EI)×2 were prepared by
203 dissolving the pure recombinamers in PBS at 4 °C for 16 h. Once the
204 recombinamers had completely dissolved, pictures were taken at 4 °C.
205 Thereafter, the recombinamers were placed at room temperature, and
206 after 2 min, the samples were inverted and pictures were taken.
207 Stability in an Excess of Aqueous Medium. A solution of each
208 recombinamer at 15 wt % was prepared by dissolving pure lyophilized
209 polymer in aqueous solution (PBS) in glass vials. Once the solution
210 had been obtained, it was incubated at 37 °C for 10 min to ensure
211 hydrogel formation. Immediately afterward, 1.5 mL of PBS was added
212 to the preformed hydrogels. The hydrogels with PBS were placed in a
213 shaker, at 50 rpm and 37 °C and photographs taken at diﬀerent times
214 (0, 30, 60, and 120 min) in order to monitor the evolution and
215 stability of the hydrogels. After 2 h in the shaker, the erosion of the
216 hydrogels was quantiﬁed by spectroscopic methods, measuring the
217 absorbance and by electrophoretic analysis, analyzing the intensity
218 band using KODAK 1D 3.6 software.
219 Macroscopic Features: Rheology. The mechanical properties of
220 the hydrogels were measured using rheological tests in a controlled
221 stress rheometer (AR2000ex, TA Instruments) equipped with a Peltier
222 plate temperature control.
223 The conversion of the solution to a gel in the sol−gel process was
224 studied for the three recombinamers (EI)×2, (EI-ZC)×2, and (EI-
225 ZL)×2. A parallel-plate geometry of 20 mm in diameter and a sample
226 volume of 350 μL in PBS was used. The temperature ramp, kinetics of
227 gelation, and the stability over time were carried out at a constant
228 strain of 0.5% and a frequency of 10 Hz. Temperature ramp
229 experiments were performed by heating the sample from 5 to 40 °C.
230 The heating rate was 2.5 °C/min, and the reverse process (cooling)
231 was performed under the same conditions. The kinetics of the gelling
232 process and stability over time was measured at 37 °C.
233 Circular Dichroism Spectroscopy. Recombinamers were dis-
234 solved at a ﬁnal concentration of 1 mg/mL and were kept overnight at
235 4 °C. A 1:10 dilution was prepared immediately prior to performing
236 each measurement. The CD spectrum was acquired using a Jasco J-815
237 150-S spectrometer, using a quartz cuvette with a path length of 0.1
238 cm. Scans were obtained over the wavelength range 190−260 nm at
239 experimental temperatures of 5 and 37 °C by acquiring points every
240 0.5 nm using a scan speed of 50 nm/min. Samples were equilibrated
241 for 15 min prior to each measurement. Spectra were corrected by
242 subtracting the corresponding blank solvent readings. The data are
243 expressed molar ellipticity [θ], which was calculated as follows:
244 ellipticity/[path length (cm) × concentration (mol/L) × 10].
245 Nanostructured Properties. Dynamic Light Scattering (DLS).
246 Solutions of (EI-ZC)×2, (EI-ZL)×2, and (EI)×2 were prepared by
247 dissolving pure, lyophilized products to a concentration of 25 μM in
248 PBS. They were kept at 5 °C for 16 h to allow complete dissolution of
249 the recombinamers, then were ﬁltered using a 0.45 μm PVDF syringe
250 ﬁlter. Dynamic light scattering (DLS) measurements were performed
251 using a Zetasizer Nano Series (Malvern Instrumens) equipped with a
252 10 mW He−Ne laser at a wavelength of 633 nm. Samples were
253 introduced into polystyrene cuvettes and stabilized for 5 min at the
254 desired temperature. Autocorrelation functions were used to obtain
255 the size distribution and polydispersity index.
256Atomic Force Microscopy (AFM). Stock solutions of (EI-ZC)×2,
257(EI-ZL)×2, and (EI)×2 were prepared by dissolving pure, lyophilized
258products to a concentration of 25 μM in PBS and ﬁltered using a 0.45
259μm PVDF syringe ﬁlter. They were then kept at 4 °C for 16 h to allow
260complete dissolution of the proteins. A drop (50 μL) of each sample
261was deposited onto a clean graphite (HOPG, highly ordered pyrolitic
262graphite) surface and the dry samples analyzed using a Multimode 8
263AFM attached to a Nanoscope V electronics (Bruker) instrument in
264tapping mode.
265Cell Viability. HFF-1 (human foreskin ﬁbroblasts) cell line was
266used as cell model to test the cytocompatibility of the ZELRs.
267Fibroblasts are the predominant cell type in the extracellular matrix
268(ECM) and, thereof, represent one of the main portals of exposition of
269biomaterials, which justiﬁes the selection of this cell line.
2707500 HFF-1 cells were seeded onto 96-well culture plates. The
271culture medium was removed after 5 h and replaced by 100 μL of the
272corresponding sterile recombinamer solution in DMEN medium at a
273concentration of 25 μM. Testing the dispersion of the recombinamers
274instead of a hydrogel was motivated by current concerns that point to
275the generation of particulate debris as one of the major causes of
276failure of any biomaterial implant.21 In the case of the negative
277controls, 100 μL of DMEN medium (without any recombinamer) was
278added.
279Live and dead staining (LIVE/DEAD Viability/Cytoxicity Assay Kit,
280Invitrogen) was used according to the manufacturer’s instructions, and
281ﬂuorescence intensity emission was measured at 425 and 620 nm after
282excitation at 485 and 525 nm (SpectraMax M5e (Molecular Devices)
283microplate reader). The ﬂuorescence intensity was converted into a
284number of HFF-1 cells by using calibration curves obtained with
285known numbers of HFF-1 cells seeded on 96-well plates 24 h before
286the measurement (from 1000 to 20000 cells per mL, using 100 μL of
287DMEN medium). Additionally, cells were visualized with a Nikon
288eclipse Ti-SR (Japan) ﬂuorescence microscope and images taken.
289Three independent experiments, each in triplicate, were performed for
290each recombinamer.
291Porous Structure. ZELR hydrogels were dropped into liquid
292nitrogen and freeze-dried. Imaging of the ZELR hydrogels was
293performed using a FEI Quanta 200 FEG instrument in low vacuum
294mode with no prior coating procedures. SEM images were employed
295to determine hydrogel microstructures.
296■ RESULTS AND DISCUSSION
297Design and Construction of ZELR and ELR. The amino
298acid sequences of the diﬀerent constructs (EI)×2, (EI-ZC)×2,
299 t1and (EI-ZL)×2 are shown in Table 1. For the sake of
300simplifying the nomenclature, the HLF motif is referred to in
301the present work as ZC, whereas ZL- refers to the mutated
302version of ZC, which is characterized by the presence of leucine
303(L) in the “d” position of the fourth heptad instead of a
304cysteine (C) (Table 1). EI- stands for the amphiphilic EL-block
305in which glutamic acid (E) and isoleucine (I) are the guest
306residues in the hydrophilic and hydrophobic blocks, respec-
307tively. A schematic diagram showing the diﬀerent domains of
308(EI)×2, (EI-ZC)×2, and (EI-ZL)×2 is provided in Figure S1
309(Supporting Information).
Table 1. Amino Acid Sequence of the Diﬀerent Recombinamersa
abbreviated
name amino acid sequence zipper origin
(EI)×2 MESLLP-{[(VPGVG)2-(VPGEG)-(VPGVG)2]10[VPGIG]60}2-V _
(EI-ZC)×2 MESLLP-{[(VPGVG)2-(VPGEG)-(VPGVG)2]10[VGIPG]60-
[VGGGGGKENQIAIRASFLEKENSALRQEVADLRKELGKCKNILAKYEAGGGGG]}2-V
natural (human)
Q16534
(EI-ZL)×2 MESLLP-{[(VPGVG)2-(VPGEG)-(VPGVG)2]10[VGIPG]60-
[VGGGGGKENQIAIRASFLEKENSALRQEVADLRKELGKLKNILAKYEAGGGGG ]}2-V
mutated
aThe natural or mutated feature of the Z-motif of each recombinamer is also indicated. The identiﬁer assigned by UniProtKB data base to the
transcription factor that contains the Z-motif used here is also provided. A dash indicates absence of Z-domains. Note that the mutated Z-moiety
displays a leucine (L) in the “d” position of the fourth heptad instead of a cysteine (C).
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310 (EI)×2 construction and puriﬁcation has already been
311 reported.16 Relative to (EI-ZC)×2 and (EI-ZL)×2, sequential
312 introduction of the repetitive polypeptide-coding gene seg-
313 ments to form fusion genes with a fully controlled composition
314 and chain length was carried out using the recursive directional
315 ligation (RDL) technique.20 DNA sequencing and restriction
316 mapping analysis showed the correctness of the gene
317 construction process.
318 ZELR Production and Puriﬁcation. ZELR puriﬁcation
319 was successfully carried out using the optimized ITC protocol.
320 To the best of our knowledge, this is the ﬁrst time that an
321 elastin-zipper based molecule has been puriﬁed using such an
322 approach. Although chromatography has been widely applied
323 for the puriﬁcation of Z-based molecules,8−10 this technique is
324 expensive and diﬃcult to scale-up. Here, we have successfully
325 made use of the reversible inverse transition of the EL- moieties
326 to purify the whole ZELR hybrid molecule under water-based
327 and mild conditions. Production yields of around 100 mg per
328 liter of bacterial culture were achieved. The ﬁnal product was
329 characterized by SDS-PAGE electrophoresis (Figure S2),
330 MALDI-TOF mass spectrometry (Figure S3), NMR (Table
331 S1), and amino acid analysis (Table S2), which conﬁrmed the
332 purity and correctness of the biosynthetic process in terms of
333 sequence and molecular mass. DSC experiments were
334 performed in order to check the Tt of the recombinamers
335 (Figure S4).
336 Visualization of the Sol−Gel Behavior. Thermogelling
337 Behavior. Macroscopic observation of the systems clearly
338 indicated that freshly prepared solutions of the three
339 recombinamers, with and without zipper domains, underwent
340 a rapid sol−gel transition upon increasing the temperature
341 above the Tt. Moreover, a liquid-like state was recovered upon
f1 342 lowering the temperature below the Tt (Figure 1).
343 The Z-motif selected here for the construction of ZELRs is
344 classiﬁed as a dimerization sequence as the establishment of
345 higher-order associations is hampered.6,22 Therefore, when
346 performing our molecular design, we speculated that the
347 formation of a network involving only Z-associations would be
348 hampered by the inclusion of only two HLF motifs per
349molecule (Table 1), thereby ensuring a liquid-like state of the
350system when no additional intermolecular contacts mediated by
351the amphiphilic EL- domains were present, in other words
352below the Tt of the EL moieties. Such behavior is an essential
353requirement to achieve an injectable formula. The liquid-like
354state displayed by ZELR at 5 °C supports the basis of our
355rational design, with just two dimerizing Z-domains being
356engineered per molecule to avoid the formation of insoluble
357networks. Above the Tt of the EL-moieties, it is expected that
358both kinds of interaction, namely, those mediated by Z- and
359EL-moieties, would coexist, thus, resulting in the subsequent
360formation of a hydrogel.
361Given the potential utility of these systems in tissue
362engineering, where in vitro cell cultures require transparent
363optical properties of hydrogels in order to allow a correct
364visualization of cell behavior within the scaﬀold, their
365transparency properties were checked. As shown in Figure 1,
366visualization through the corresponding hydrogels was apparent
367in all cases.
368Stability in an Excess of Aqueous Medium. To check the
369stability in an excess of aqueous medium, PBS was added to
370preformed 15 wt % hydrogels, as described in the Experimental
371Section.
372The stability of these hydrogels over time clearly diﬀered
373 f2(Figure 2). Thus, immediately after the addition of PBS, the
374(EI)×2 hydrogel disaggregated completely, with only a slightly
375turbid solution remaining (Figure 2c). This contrasts with the
376behavior displayed by (EI-ZC)×2 and (EI-ZL)×2 hydrogels
377(Figure 2a,b). Furthermore, (EI-ZC)×2 remained apparently
378unaltered for at least 2 h (Figure 2d−j), whereas the slight
379turbidity present in the excess of aqueous medium for the (EI-
380ZL)×2 hydrogel pointed to a slight disintegration of the system
381(Figure 2k), although most of the gel remained as such on the
382bottom of the vial. In all three cases the amount of
383recombinamer disaggregated from the gel-state was quantiﬁed
384and it was found that, whereas (EI)×2 was completely
385disaggregated, only 30% of the (EI-ZL)×2 recombinamer was
386dissolved from the gel state. Furthermore, for (EI-ZC)×2, only
3872% of the recombinamer was transferred from the gel to the
388excess of aqueous medium.
389In light of the above, the presence of the Z-motifs clearly
390improves the stability of the hydrogel when compared to the
391control. Moreover, when comparing the stability features of
392both versions of ZELR hydrogels, the gel containing cysteine is
393more stable than the mutated version containing leucine. As
394such, we hypothesize that disulﬁde bond formation is
395responsible of this increased stability. It is worth noting that
396the stability of the hydrogel (EI-ZL)×2 is achieved exclusively
397by means of physical interactions.
398Macroscopic Features: Rheological Characterization.
399Time Required for Gelation and Stability. After checking the
400reversible thermogelling process exhibited by the ZELRs, their
401stability over time was estimated by rheological methods by
402applying an isotherm at 37 °C to a sample initially kept at 5 °C.
403 f3As shown in Figure 3, both ZELRs showed signiﬁcantly
404enhanced stability compared to the control ELR (EI)×2. Thus,
405whereas the (EI)×2 sample undergoes a transient gel state,
406which lasts only a few minutes, after which the gel state
407disappears, (EI-ZC)×2 and (EI-ZL)×2 remain in a gel state for
408the entire time interval studied. Moreover, diﬀerences in
409stability between (EI-ZL)×2 and (EI-ZC)×2 were also
410detected. Thus, while (EI-ZC)×2 displays a stable modulus
411(1300 Pa), (EI-ZL)×2 experiences a sustained decrease in its
Figure 1. Pictures showing the liquid-like state of the three
recombinamers at low temperature and their ability to form hydrogels
upon increasing the temperature above the Tt. Visualization of the
transparency of (a) (EI-ZC)×2, (b) (EI-ZL)×2, and (c) (EI)×2
hydrogels at 15 wt %.
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412 mechanical properties until stability is achieved at 150 Pa
413 (Figure 3b). Since the only diﬀerence between (EI-ZC)×2 and
414 (EI-ZL)×2 is the substitution of two cysteine residues by two
415 leucines (Table 1), it can be concluded that this substitution is
416 responsible for the diﬀerences regarding the stability proﬁle of
417 both recombinamers.
418 Additionally, the gelation time was less than 1 min for both
419 ZELR solutions (Figure 3). Since the solutions were able to
420 form a gel in a matter of seconds, these materials are potential
421 candidates for use as injectable hydrogels. Moreover, such a
422 short gelation time would presumably avoid diﬀusion events
423 once the biomaterial is injected, with the consequent
424advantages for its application, such as a reduction in the loss
425of active substances, and consequent improvement in the
426eﬃcacy of the therapy. The achievement of both features (rapid
427gelling and stability) represents an important step forward in
428the development of Z-based hydrogels.
429Dependence of Gel State on Temperature. In order to
430quantify their mechanical properties with regard to temper-
431ature, 15 wt % (EI)×2, (EI-ZC)×2, and (EI-ZL)×2 solutions
432were subjected to a rheological study consisting of heating from
4335 to 40 °C at a rate of 2.5 °C/min.
434 f4As shown in Figure 4, gel formation occurred for the three
435samples in the temperature range of 12−18 °C, as is evident
Figure 2. Pictures showing the stability features of (EI-ZC)×2, (EI-ZL)×2, and (EI)×2 after diﬀerent incubation times at 37 °C while shaking at 50
rpm with an excess of aqueous medium.
Figure 3. Stability performance of the hydrogels. Isotherms for (EI-ZC)×2, (EI-ZL)×2, and (EI)×2 at 37 °C. (a) Evolution of the complex modulus
(G*) with time for the three recombinamers. (b) Elongation of the isotherm for (EI-ZL)×2 recombinamer until stabilization of the complex
modulus is achieved.
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436 from the G′−G″ crossover. However, the gel state for (EI)×2 is
437 not stable over the whole temperature range measured, and
438 although a gel state of 1700 Pa is achieved at 25 °C, at
439 physiological temperature (37 °C) and under these conditions
440 (15 wt % and PBS), the gel state disappears. This behavior
441 contrasts with the behavior exhibited by (EI-ZC)×2 and (EI-
442 ZL)×2, in which the gel state is maintained at 37 °C.
443 In order to verify the reversibility of the thermogelling
444 process, a cooling ramp was applied from 40 to 5 °C and the
445 resulting mechanical properties monitored. As shown in Figure
446 4, the thermogelling process is completely reversible. Moreover,
447 the gelation temperature for both (EI-ZC)×2 and (EI-ZL)×2
448 coincides with that displayed by (EI)×2. These ﬁndings suggest
449 that the elastomeric portion exerts an active role in the
450 thermogelling process, with the presence of zipper motifs being
451 essential to achieve ﬁnal stabilization of the system.
452 Furthermore, (EI-ZC)×2 and (EI-ZL)×2 do not display a gel
453 state at 5 °C, which is indicative that the Z-motif is not able to
454 maintain a network state by itself when the surrounding
455 elastomeric hydrophobic moieties are in a randomly hydrated
456 state. This observation is in accordance with our rational design
457 of the ZELR molecules, into which just two Z-moieties per
458 molecule were engineered in order to promote a liquid-like
459 state of the system at lower temperatures.
460Circular Dichroism Spectroscopy. Circular dichroism
461(CD) spectroscopy analysis was performed to detect whether
462the previously described rheological observations are related to
463changes in the conformational state of the molecule and
464especially to shed light on the conformational state of the Z-
465domain.
466 f5Figure 5 shows CD spectra for (EI)×2, (EI-ZL)×2, and (EI-
467ZC)×2 at 5 and 37 °C. At 5 °C, an intensely negative band at
468197 nm, which is indicative of a predominantly disordered
469structure, is displayed by (EI)×2. The CD spectra of both (EI-
470ZC)×2 and (EI-ZL)×2 show a reduced negative band at
471around 200 nm and an increased negative band at around 220
472nm when compared with the spectrum of (EI)×2. These
473observations suggest that both (EI-ZL)×2 and (EI-ZC)×2 have
474a higher α-helix content than (EI)×2. At 37 °C, the CD
475spectrum of (EI)×2 displays a weaker negative signal at 197 nm
476than that present at 5 °C, whereas the magnitude of the signal
477at 210 nm increased, thus, suggesting the induction of a type II
478β-turn conformation with an increase in temperature, as has
479previously been observed for EL macromolecules.23,24 In
480contrast to (EI)×2, which adopted a type II β-turn
481conformation, the spectra for (EI-ZC)×2 and (EI-ZL)×2
482resemble that of an α-helical structure, although with some
483subtle modiﬁcations. Thus, a typical α-helical spectrum is
Figure 4. Storage and loss moduli (G′, G″) for (EI-ZC)×2, (EI-ZL)×2, and (EI)×2 solutions (15 wt %) as a function of temperature: (a) (EI-
ZC)×2 during heating; (b) (EI-ZC)×2 during cooling; (c) (EI-ZL)×2 during heating; (d) (EI-ZL)×2 during cooling; (e) (EI)×2 during heating; (f)
(EI)×2 during cooling.
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484 characterized by a minimum ellipticity at 222 and 208 nm.
25
485 (EI-ZC)×2 and (EI-ZL)×2 show such minima at 222 and 201
486 nm. This displacement suggests the presence of a mixture of β-
487 turns and α-helix structures, which agrees with a contribution of
488 both EL- and Z-moieties to the ﬁnal conformation. The
489 spectrum for (EI)×2 was subtracted from those for (EI-ZC)×2
490 and (EI-ZL)×2 to more clearly discern the α-helical
491 conformation attributable to the Z-domains.
492 In order to examine the reversibility of the conformational
493 changes observed upon varying the temperature, the CD
494spectra of these recombinamers were recorded upon cooling.
495This showed that the thermally induced conformational
496changes are completely reversed upon lowering the temper-
497ature (Figure 5c−f). These ﬁndings are in agreement with the
498reported rheological data, which also showed a reversible
499thermogelling behavior (Figure 4). It is noteworthy that the Z-
500domains remain in an α-helical conformation at both
501temperatures (5 and 37 °C).
502As a consequence, the enhanced stability triggered upon
503raising the temperature (and which is not present in the
Figure 5. CD spectra of (EI)×2, (EI-ZL)×2, and (EI-ZC)×2 at diﬀerent temperatures; Subtraction of CD spectrum for (EI)×2 from those for (EI-
ZL)×2 and (EI-ZC)×2, respectively: (a, d) 5 °C; (b, e) 37 °C; (c, f) 5 °C (after heating to 37 °C, to check the reversibility of the conformational
changes).
Figure 6. Volume-distribution proﬁles at 5 °C and at 37 °C for (EI)×2, (EI-ZL)×2, and (EI-ZC)×2.
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504 material without Z-domains, namely, (EI)×2) is a consequence
505 of a synergistic eﬀect between both EL- and Z-domains, and no
506 conformational changes in the latter are involved in this
507 increased stability.
508 Nanostructured Properties. After having studied both the
509 macroscopic and the molecular behavior of these materials, the
510 next step was to determine any diﬀerences between the three
511 recombinamers at the nanoscale level.
f6 512 Dynamic Light Scattering (DLS). Figure 6 shows the
513 particle-size and volume distributions at both 5 and 37 °C for
514 the three recombinamers. In all three cases, nanoparticles are
515 formed upon increasing the temperature from 5 to 37 °C. In
516 particular, (EI)×2 self-assembles into nanoparticles of 35 nm,
517 with a low polydisperisty value of 0.05, thereby indicating a low
518 variation in particle size. Although nanoparticles of a similar size
519 to (EI)×2 are formed by both ZELRs, the polydispersity values
520 indicate a more heterogeneous population. An enlarged view of
521 the volume-distribution proﬁles conﬁrms these diﬀerences
522 (Figure 6d).
523 It is worth noting that the size distribution of ZELRs is also
524 more heterogeneous than that for (EI)×2 at 5 °C, as can clearly
525 be seen from the enlarged view of the distribution proﬁle
526 (Figure 6b). This observation further supports the notion that
527 the Z-motifs interact at 5 °C and that the liquid-like state is
528 maintained due to the limited number of Z moieties per
529 molecule included in their molecular design, with the
530 subsequent importance of this for the achievement of an
531 injectable system.
532 Atomic Force Microscopy (AFM). AFM was used to visualize
533 the structures detected in the previous DLS studies. As shown
f7 534 in Figure 7, the three recombinamers form spherical nano-
535 particles at 37 °C, although clear diﬀerences exist in regard to
536 the homogeneity of the nanoparticle populations. Thus,
537 whereas (EI)×2 self-assembles into a deﬁned and homoge-
538 neous population, (EI-ZC)×2 and (EI-ZL)×2 adopt a more
539 heterogeneous proﬁle, with particle sizes ranging from 25 to
540 100 nm. Thus, Figure 7b shows that the largest nanoparticle has
541 remnants of the smaller ones, thereby pointing to a possible
542 process of formation of the bigger nanoparticles involving
543fusion of the smaller ones. Considering that the only diﬀerence
544between the ZELR molecules and (EI)×2 is the presence of a
545zipper motif in the former, it can be concluded that this motif
546plays an important role in the observed fusion of the smaller
547nanoparticles, giving rise to the more heterogeneous
548population. These results are in agreement with the DLS
549measurements. This tendency to higher aggregation displayed
550by ZELRs when compared to ELRs at the nanoscopic level may
551be related to the greater stability observed at the macroscopic
552scale and at higher concentrations. Thus, whereas ELR
553molecules fail to form a stable hydrogel due to gel
554disaggregation and micelle dispersion, ZELRs appear to self-
555assemble into entangled and locked micelles in which the
556presence of Z-moieties seems to block the disentanglement of
557bridged micelles.
558Cell Viability. Due to the envisaged biomedical applications
559of these recombinamers, LIVE/dead assays were performed in
560order to check their cytocompatibility. The quantitative analysis
561was performed by measuring the corresponding ﬂuorescence
562emitted by both calcein and EtDH-1 under the three conditions
563tested, namely, HFF-1 culture treated with (EI-ZC)×2, (EI-
564ZL)×2, or with any treatment (control), as detailed in the
565Experimental Section. A one-way analysis of variance
566(ANOVA) revealed no statistically signiﬁcant diﬀerences in
567viability between the treatment groups, namely, (EI-ZC)×2,
568(EI-ZL)×2, and control (without recombinamer).
569 f8Microscopic observation corroborated these ﬁndings (Figure
570 f88). Furthermore, no morphological diﬀerences were observed
571between the control ﬁbroblasts and the ﬁbroblasts treated with
572the recombinamers.
573Porous Structure. SEM was used to observe the internal
574 f9structure of the hydrogels. As can be seen from Figure 9, both
575(EI-ZC)×2 and (EI-ZL)×2 hydrogels showed a highly porous
576structure, with an important level of interconnection between
577the pores. Moreover, the diameter of many of the observed
578pores is around 20 μm, and is thus in the same size range as
579that displayed by most human cells, with the obvious
580importance of this fact in view of theirs potential biomedical
581applications.
Figure 7. Representative AFM images of the nanostructures derived from (EI-ZC)×2, (EI-ZL)×2, and (EI)×2 deposited on an HOPG surface at 37
°C. (a) (EI-ZC)×2 with a scanning window of 2 μm. (b) (EI-ZC)×2 with a scanning window of 0.5 μm. Green arrows mark some representative
smaller particles, whereas the black arrow marks a representative largest nanoparticle, apparently formed by fusion of smaller ones. (c) (EI-ZL)×2
with a scanning window of 2 μm. (d) (EI-ZL)×2 with a scanning window of 0.5 μm. (e) (EI)×2 with a scanning window of 2 μm. (f) (EI)×2 with a
scanning window of 0.5 μm.
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582 ■ CONCLUSION
583 Reversible binding events between macromolecules play a
584 crucial role in regulating many biological processes and
585 represent the central axis of dynamic chemistry. Although
586 many examples of the extrapolation of biological designs to the
587 creation of artiﬁcial machines can be encountered, a better
588 understanding of the rules that govern the assembly and
589 interactions between the diﬀerent motifs found in the Nature is
590 required in order to make the most of their potential for
591 designing advanced functional materials.
592 In this study we report an innovative zipper-elastin-like
593 (ZEL-) molecule in which the connecting blocks between Z-
594 domains have been engineered to form thermally responsive
595 amphiphilic EL tetrablocks. Although some examples of Z-
596 based physical hydrogels have been reported in the literature, in
597 all cases the connecting blocks are essentially spacers with no
598 eﬀect on Z-domain association. As such, the propensity of the
599 selected Z-moiety to dimerize, together with the unique
600thermosensitive behavior of EL moieties, has been exploited
601to form a reversible, injectable and stable hydrogel.
602Furthermore, the stability of this hydrogel points to a positive
603cooperative eﬀect26 in which the interaction between the Z-
604and EL-moieties makes the stability of the assembly as a whole
605signiﬁcantly higher than that displayed by the system in which
606just one of the two motifs is interacting. To the best of our
607knowledge, this is the ﬁrst time that such a synergistic eﬀect
608between both kinds of domains has been reported. In addition,
609some clues regarding the enhanced stability have been found at
610the nanoscale level, with the presence of Z-motifs seeming to
611induce the aggregation of micelles, thereby pointing to a
612bridged-micelle structure.
613In light of the above, and bearing in mind the potential
614designs oﬀered by recombinant production, the next step will
615focus on the development of a battery of ZELRs including
616tailored biofunctionalities in order to use these materials for
617speciﬁc applications in the biological and biomedical ﬁelds.
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